SB
ALMS

Samsara BioCapital’s Alumis Inc ALMS Stock Holding History

Samsara BioCapital’s Portfolio ALMS Stock Details ALMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179M Hold
6,345,219
– – 14.67% 2
2026
Q1 		$140M Buy
6,345,219
+588,235
+10% +$14.7M 13.58% 3
2025
Q4 		$56.2M Buy
5,756,984
+955,614
+20% +$6.67M 5.8% 5
2025
Q3 		$19.2M Hold
4,801,370
– – 2.5% 6
2025
Q2 		$14.4M Buy
4,801,370
+1,534,872
+47% +$7.25M 2.95% 8
2025
Q1 		$20.1M Hold
3,266,498
– – 3.58% 5
2024
Q4 		$25.7M Hold
3,266,498
– – 3.52% 8
2024
Q3 		$34.9M Buy
+3,266,498
New +$39.6M 6.71% 5

Other funds holding ALMS

ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $426M AUM 838% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Samsara BioCapital's ALMS Position: Q2 2026 in Review

Samsara BioCapital held its Alumis Inc (ALMS) position steady in Q2 2026 at 6,345,219 shares worth $179M. The position accounts for 14.67% of the portfolio, ranked #2.

Samsara BioCapital first reported a position in ALMS in Q3 2024 and has held it in 8 quarters since. 198 funds tracked by Wall St. Rank hold ALMS as of Q2 2026.

  • Samsara BioCapital held 6,345,219 shares of Alumis Inc worth $179M as of Q2 2026.
  • Samsara BioCapital left its Alumis Inc share count unchanged in Q2 2026.
  • Alumis Inc made up 14.67% of Samsara BioCapital's portfolio in Q2 2026, its #2 holding.
  • Samsara BioCapital first reported a position in Alumis Inc in Q3 2024 and has held it in 8 quarters since.
  • 198 funds tracked by Wall St. Rank held Alumis Inc as of Q2 2026.

Based on Samsara BioCapital's 13F filing for Q2 2026, filed 14 Aug 2026.